House Energy Chair Brett Guthrie said he hopes to revive the health legislation that was pushed out of the American Relief ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...

"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

The Pharmaceutical Care Management Association, which represents PBM's, called the FTC report baseless and "without ...

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

The pharmaceutical supply chain is a sector infamous for glacially slow adjustments, lackluster reform, lack of transparency ...

CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...

The time is right for PBM reform, but the American people might be better served if Congress goes back to the drawing board ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...